ARTES and Burnet Institute publish data on production and immunogenicity of malaria transmission-blocking vaccine candidates

ARTES Biotechnology and Burnet Institute recently published data on the efficient production of malaria vaccine candidates using virus-like particles (VLP) presenting malaria transmission-stage antigens, which were capable of inducing transmission-blocking antibodies.

ARTES attends BioEurope Spring 2019

Meet us at the Bio-Europe Spring 2018 tak­ing place in Vienna, Austria March 25 -27. Volker Jenzelewski, Direc­tor Technology at ARTES, will be present in the One-on-One Part­ner­ing presenting ARTES’ innovative range of cell line and process development solutions for bio-pharmaceutical and vaccine products.

SplitCore – the latest milestone in ARTES´ vaccine development offer

ARTES Biotechnology announces the acquisition of the unique SplitCore technology developed by scientists at the University of Freiburg, Germany.